Hyperlipidemia in Saudi Arabia

Saudi Medical Journal

Volumn 29, Issue 2, 2008, Pages 282-287

  Al Nozha, Mansour M ^a,f   Arafah, Mohammed R ^a   Al Maatouq, Mohammed A ^a   Khalil, Mohamed Z ^a   Khan, Nazeer B ^b   Al Marzouki, Khalid ^c   Al Mazrou, Yaqoub Y ^d   Abdullah, Moheeb ^e   Al Khadra, Akram ^d   Al Harthi, Saad S ^a   Al Shahid, Maie S ^e   Al Mobeireek, Abdulellah ^a   Nouh, Mohammed S ^a  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^b DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^d IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

^e KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^f TAIBAH UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; EATING HABIT; FEMALE; HEALTH BEHAVIOR; HEALTH PROMOTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PREVALENCE; RISK ASSESSMENT; RISK REDUCTION; RURAL POPULATION; SAUDI ARABIA; SEX DIFFERENCE; URBAN POPULATION;

ADULT; AGED; BODY MASS INDEX; EXERCISE; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIAS; HYPERTRIGLYCERIDEMIA; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; RURAL POPULATION; SAUDI ARABIA; SEX FACTORS; SOCIOECONOMIC FACTORS; URBAN POPULATION;

EID: 40749093300     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Wilson PW, D'Agistino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1847.
2. Grundy SM, Balady GJ, Criqui MH, Fletcher G, Greenland P, Hiratzka LF, et al. Guide to primary prevention of cardiovascular disease. A statement for healthcare professionals from the Task Force on Risk Reduction. American Heary Association Science Advisory and Coordinating Committee. Circulation 1997; 95: 2329-2331.
3. wilson PW. Established risk factors and coronary artery disease: The, Framingham Study. Am J Hypertens 1994; 7: S7-S12.
4. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary Screenees of the Multiple Risk Facror Intervention Trial (MRFIT). JAMA 1986; 256: 2823-2828.
5. Stamler J, Daviglus ML, Garside DB, Dyer AR. Greenland P, Neaton JD. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term caronary, cardiovascular, and all-cause mortality and to longevity. JAMA 2000; 284: 311-318.
6. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-hased prospective studies. J Cardiovasc Risk 1996; 31: 213-219.
7. Ferrieres J, Lambert J, Lussier-Cacan S, Davignon J. Coronary artery disease in the heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation. Circulation 1995; 92: 290-295.
8. Hopkins PN, Stephenson S, Wu LL. Riley WA, Xin Y, Hunt SC. Evaluation of coranaty risk factors in patients with heterozygous familial hypercholesterolemia. Am J Cardiol 2001, 87: 547-553.
9. Seed M. Hoppichler F, Reavely D, McCarthy S, Thompsom GR, Boerwinkle E, et al. Relation of serum lipoprotein (a) concentration and apolipopratein (a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Eng J Med 1990; 322: 1494-1499.
10. Wiegman A, Rodenburg J, de Jongh S, Defesche JC, Bakker HD, Kastelein JJ, et al. Family histoty and cardiovascular risk in familial hypercholesterolemia: Data in more than 1000 children. Circulation 2003, 107: 1473-1478.
11. Lee MH, Lu K, Hazard S, Yu H, Shulenin S, Hidaka H, et al. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 2001; 27: 79-83.
12. O'Brien Dinneen SF, O'Brien PC, Palumbo PJ. Hyperlipidemia in patients with primary, and secondary hypothyroidism. Mayo Clin Proc 1993; 68: 860-866.
13. Osser DN, Najarian DM, Dufresne RL. Olanzapine increases weight and serum triglyseride levels. J Clin Psychiatry 1999; 60: 767-770.
14. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronarY heart disease: The Scandinavian simvastatin survival study (4S). Lancet 1994; 344: 1383-1389.
15. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. Prevention of coronary heart diseases with pravastatin in men with hypercholesterolaemia. Wesy of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1301-1307
16. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TextCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998; 1615-1622.
17. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effecl of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996; 335: 1001-1009.
18. Prevention of cardivascular events and death with pravastatin in patients with coronary heart disease and broad range of initial Cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Engl J Med 1998; 339: 1349-1357.
19. Kane JP, Malloy MJ, Ports TA, Phillips NR, Diehl JC, Havel RJ. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 1990; 264: 3007-3012.
20. Gould AL, Rossouw JE, Santanello NC, Heyse JF, Furberg CD. Cholesterol reduCtion yields clinical benefit: Impact of statin trials. Circulation 1998; 97: 946-952.
21. Al-Nozha MM, Arafah MR, Al-Mazrou YY, Al-Maatouq MA, Khan NB. KhAlil MZ, et al. Coronary artery disease in Saudi Arabia. Saudi Med 2004; 25: 1165-1171.
22. Al-Nuaim AR, Serum total and fractionated cholesterol distribution and prevalence of hypercholeterolemia in urban and rural communities in Saudi Arabia. Intl J Cardiol 1997; 58: 141-149.
23. Al-Nuaim AR, Al-Rebeann K. Al-Mazrou Y, Al-Attas O, Al-Dagliari N. Serum total, fractionated cholesterol concentration distribution and prevalence of hypercholesterolemia in Saudi Arabia, regional variation. Ann Saudi Med 1997; 171: 179-184.
24. al-Nuaim AR, al-Rubeam K, al-Mazrou Y, al-Attas O, al-Daghari N. Prevalence of hypercholesterolemia in Saudi Arabia, epidemiological study. Int J Cardiol 1996; 54: 41-49.
25. Third-Report of t6c National Cholesterol Education Program (NCE11) FxpcA Panel on Da=iort, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421.
26. Al-Hazzaa HK Prevalence of physical inactivity in Saudi Arabia: A brief review. East Mediterr Health J 2004; 10: 663-670.
27. Al-Nozha MM, Al-Hazzaa HM, Arafah MR, Al-Khadra A, Al-Mazzrou YY, Al-Maatouq MA, et al. Prevalence of physical activity and inactivity among Saudis ageg 30-70 years. A population-based cross-sectional study. Saudi Med J 2007; 28: 559-568.
28. Ford ES, Mokdad AH, Giles WH, Mensah GA. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: Findings from the National Health and Nutrition Examination Survey, 1999 to 200O. Circulation 2003; 107: 2185.
29. al-Shammari SA, Ali M, al-Shammari A, al-Maatouq M, Tennier A, Armstrong K. Blood lipid corcentration and other cardiovascular risk factors among Saudis. Fam Pract 1994; 11: 153-158.
30. Park Y, Lee H, Koh CS, Min, H. Community-based epidemiologic study on atherosclerotic cardiovascular risk factors. Diabetes Res Clin Pract 1996; 34 Suppl: S65-S72.
31. Opadijo OG, Akande AA, Jimoh AK, Prevalence of coronary heaer disease risk factors in Nigerians with systemic hypertension, Afr J Med Sci 2004; 33: 121-125.
32. Lopatynski J. Mardarowicz G, Nicer T, Szczesniak G, Krol H, Matej A, et al. The prevalence of type II diabetes mellitus in rural urban population over 35 years of age in Lublin region (Eastern Poland). Pol Arch Med Wewn 2001; 106: 781-786.
33. Gupta R, Sarna M, Thanvi J, Rastogi P, Kaul V, Gupta VP. High prevalence multiple coronary risk factors in Punjabi Bhatia community: Jaipur Heart Watch-3. Indian Heart J 2004; 56: 646-652.
34. Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, et al. Secular Trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 2005; 293: 1868-1874.